Clinical Trials Browser

Smoldering Multiple Myeloma × Nivolumab × Clear all

NCT02903381 2023-06-13

A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma

Phase 2 Completed

8 enrolled 16 charts

Smoldering Multiple Myeloma